To study the status of illness in children under 5 years and to study the effect of Swarnaprashan in reducing the frequency of illnesses by improving the immunity and increasing the body strength.

Study of pattern of morbidity in children under 5 years and effect of swarna prashan on morbidity status

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018759

Enrollment

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Y998- Other external cause status

Interventions

Intervention1: Swarna prashan: Group A: Trial drug (swarna prashan) (30 cases) Dose and duration: The proposed trial drug Swarna prashan will be prescribed in doses according to body weight of chil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children with recurrent respiratory infections. 2. Children with recurrent G.I.T. diseases. 3. Children with other recurrent diseases

Exclusion criteria

Exclusion criteria: 1. Subjects suffering from major systemic illness necessitating long term treatment. 2. Subjects with evidence of malignancy. 3. Subjects with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S.creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4. Co-morbidity like TB, UTI and bleeding disorders etc. 5. H/o hypersensitivity to any of the trial drug or their ingredients. 6. Subjects who have completed participation in any other clinical trial during the past six months.

Design outcomes

Primary

Measure	Time frame
1.To study the demographic status of morbidity in children under 5 years in a defined population.Timepoint: 4 Weeks	—

Secondary

Measure	Time frame
1.To decrease the morbidity status in children with trial drug. 2.To study the immunomodulatory effect of Swarna prashan. Timepoint: 4 Weeks	—

Countries

India

Contacts

Public ContactDr Nisha Kumari Ojha

National Institute of Ayurveda Jaipur (Rajasthan)

drnishaojha@gmail.com9468650449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026